Internal Medicine, Hematology & Oncology · Stockbridge, GA
NPI
1659558823
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1240 Eagles Landing Pkwy Ste 260
Stockbridge, GA, 30281
Phone (678) 854-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
95,259 services
Medicare patients, 2024
277
Average age 74
Drug cost, 2024
$3.5M
1,858 prescriptions
Company payments, 2025
$606
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ha N Tran was code J0897 (injection, denosumab, 1 mg), 6,360 times for 27 patients. In total Ha N Tran billed 95,259 services in 107 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,360 | 27 | $19.59 | $125K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,500 | 18 | $15.16 | $38K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 942 | 17 | $0.09 | $80.87 |
| 85025 Blood Count | Office | 540 | 199 | $7.53 | $4,064 |
| 96372 Injection Administration | Office | 262 | 52 | $10.23 | $2,679 |
| 99213 Office E&M - Established | Office | 229 | 126 | $57.94 | $13K |
| 99214 Office E&M - Established | Office | 188 | 98 | $86.33 | $16K |
| 96413 Chemotherapy Administration | Office | 183 | 29 | $92.79 | $17K |
| 96367 Intravenous Infusion, Hydration | Office | 164 | 21 | $20.30 | $3,330 |
| 96375 Injection Administration | Office | 87 | 14 | $11.01 | $958 |
| 96365 Intravenous Infusion, Hydration | Office | 74 | 37 | $43.76 | $3,238 |
| 96417 Chemotherapy Administration | Office | 67 | 12 | $45.63 | $3,057 |
| 96415 Chemotherapy Administration | Office | 54 | 11 | $19.89 | $1,074 |
| 99215 Office E&M - Established | Office | 37 | 25 | $125.69 | $4,650 |
| G0008 Administration of influenza virus vaccine | Office | 29 | 29 | $32.05 | $929 |
By year: 2022 $1.4M for 83,665 services; 2023 $1.2M for 88,570 services; 2024 $1.2M for 95,259 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 540 | 199 | $7.53 | $4,064 |
Medicare prescription drug claims, 2024
In 2024, the drug Ha N Tran prescribed most often to Medicare patients was Anastrozole, with 259 prescriptions and refills. In total Ha N Tran wrote 1,858 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 259 | 699 | 77 | $4,302 |
| Eliquis Apixaban | 109 | 119 | 20 | $70K |
| Letrozole Generic | 102 | 262 | 28 | $1,976 |
| Alendronate Sodium Generic | 91 | 244 | 29 | $782 |
| Prochlorperazine Maleate Generic | 76 | 76 | 48 | $1,053 |
| Dexamethasone Generic | 53 | 57 | 37 | $1,108 |
| Tamoxifen Citrate Generic | 51 | 129 | 15 | $1,250 |
| Gabapentin Generic | 49 | 63 | 14 | $577 |
| Exemestane Generic | 47 | 103 | 13 | $5,481 |
| Potassium Chloride Generic | 47 | 55 | 22 | $324 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 41 | 41 | Under 11 | $1,049 |
| Hydroxyurea Generic | 41 | 70 | 11 | $1,566 |
| Revlimid Lenalidomide | 41 | 41 | Under 11 | $634K |
| Udenyca Autoinjector Pegfilgrastim-Cbqv | 38 | 38 | Under 11 | $154K |
| Xarelto Rivaroxaban | 36 | 52 | Under 11 | $28K |
Brand drugs: 436 claims; generic drugs: 1,422 claims; opioid claims: 114.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ha N Tran $606 ($606 in general payments such as food, travel and fees) from 15 companies. The largest payer was Cerapedics Inc. with $119.
| Company | Payments | Amount |
|---|---|---|
| Cerapedics Inc. | 1 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $55.79 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $50.09 |
| Stemline Therapeutics Inc. | 2 | $47.54 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.05 |
| Abbvie Inc. ABBV | 2 | $37.92 |
| SpringWorks Therapeutics, Inc. | 2 | $36.27 |
| Caris MPI, Inc. | 1 | $32.56 |
| Gilead Sciences, Inc. GILD | 1 | $30.66 |
| Janssen Biotech, Inc. JNJ | 1 | $28.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.